M. McLemore

发表

Extreme hyperbilirubinemia: An indicator of morbidity and mortality in sickle cell disease

R. Shah, S. Chawla, P. Reshamwala, 2019, World journal of hepatology.

Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis.

D. Link, M. Horwitz, Daniel C Link, 2002, Blood.

Congenital dyserythropoietic anemia type I: First report from the Congenital Dyserythropoietic Anemia Registry of North America (CDAR).

R. Lorsbach, T. McCavit, Wenying Zhang, 2020, Blood cells, molecules & diseases.

Characteristics and outcomes of diffuse large B‐cell lymphoma presenting in leukaemic phase

D. Weisenburger, J. Armitage, M. Bast, 2012, British journal of haematology.

Rituximab-hyperfractionated cyclophosphamide, vincristine, adriamycin and dexamethasone alternating with high-dose cytarabine and methotrexate for aggressive non-Hodgkin lymphoma

C. Flowers, S. Lonial, J. Kaufman, 2012, Leukemia & lymphoma.

High‐dose cytarabine induction is well tolerated and active in patients with de novo acute myeloid leukemia older than 60 years

K. Bhalla, H. Khoury, M. Tighiouart, 2012, Cancer.

Sensitivity and specificity of cerebrospinal fluid flow cytometry for the diagnosis of leukemic meningitis in acute lymphoblastic leukemia/lymphoma

L. Bernal-Mizrachi, H. Khoury, E. Waller, 2014, Leukemia & lymphoma.

STAT-3 activation is required for normal G-CSF-dependent proliferation and granulocytic differentiation.

D. Link, Fulu Liu, S. Grewal, 2001, Immunity.

Genistein Protects Hematopoietic Stem Cells against G-CSF–Induced DNA Damage

Erica Silva, O. Kucuk, M. Rossi, 2014, Cancer Prevention Research.

Genistein Protects Hematopoietic Stem Cells Against G-CSF Induced DNA Damage

Erica Silva, O. Kucuk, M. Rossi, 2012 .

SHORT TITLE: Genistein limits DNA Damage

Erica Silva, O. Kucuk, M. Rossi, 2014 .

Divergent Pathways in COS-7 Cells Mediate Defective Internalization and Intracellular Routing of Truncated G-CSFR Forms in SCN/AML

D. Link, B. Avalos, Alexander Copelan, 2008, PloS one.

Src family kinases are important negative regulators of G-CSF-dependent granulopoiesis.

C. Mermel, D. Link, Fulu Liu, 2006, Blood.

Transfusion‐transmitted malaria masquerading as sickle cell crisis with multisystem organ failure

S. Stowell, C. Josephson, R. Fasano, 2018, Transfusion.

G‐CSF activation of AKT is not sufficient to prolong neutrophil survival

Erica Silva, M. Mclemore, L. Souza, 2013, Journal of leukocyte biology.

Adult-onset Langerhans cell histiocytosis of bone: A case series highlighting a rare entity.

A. Bahrami, S. Oskouei, Charles Hill, 2023, Annals of Diagnostic Pathology.

Does pretreatment fluorescence in situ hybridization for BCR–ABL predict imatinib-associated hematologic toxicity in chronic myeloid leukemia?

J. Cortes, L. Bernal-Mizrachi, M. Tighiouart, 2011, Leukemia & lymphoma.

Peripheral blood monitoring of chronic myeloid leukemia during treatment with imatinib, second‐line agents, and beyond

L. Bernal-Mizrachi, H. Khoury, M. Tighiouart, 2011, Cancer.

Enhanced IgG immune response to COVID-19 vaccination in patients with sickle cell disease.

S. Stowell, J. Roback, A. Neish, 2023, British journal of haematology.

p120 nucleolar‐proliferating antigen is a direct target of G‐CSF signaling during myeloid differentiation

D. Link, Hong Sun, P. Ghosh, 2006, Journal of leukocyte biology.

Presentations and outcomes among sickle cell disease patients with COVID-19 at a large southern healthcare system

M. Hall, M. Mclemore, K. Clarke, 2022, Expert review of hematology.

Increased granulocyte colony-stimulating factor responsiveness but normal resting granulopoiesis in mice carrying a targeted granulocyte colony-stimulating factor receptor mutation derived from a patient with severe congenital neutropenia.

D. Link, J. Poursine-Laurent, M. Mclemore, 1998, The Journal of clinical investigation.

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies

L. Bernal-Mizrachi, H. Khoury, J. Galipeau, 2013, Cancer.

Prognostic significance of leukopenia at the time of diagnosis in acute myeloid leukemia.

G. Chen, Zhengjia Chen, L. Bernal-Mizrachi, 2011, Clinical lymphoma, myeloma & leukemia.

Managing chronic myeloid leukemia: a coordinated team care perspective.

H. Khoury, S. Khanwani, M. Arellano, 2012, Clinical lymphoma, myeloma & leukemia.

Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program’s Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation Study

T. Crume, N. Galadanci, J. Kanter, 2022, JMIR public health and surveillance.

Congenital Dyserythropoietic Anemia Type I Due to Biallelic CDAN1 mutations: Report from the Congenital Dyserythropoietic Anemia Registry (CDAR)

R. Lorsbach, T. McCavit, Wenying Zhang, 2019, Blood.

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second‐Generation Tyrosine Kinase Inhibitor to Imatinib

M. Arellano, M. Gaddh, E. Winton, 2017, Clinical lymphoma, myeloma & leukemia.

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia

J. Cortes, M. Grunwald, R. Stuart, 2020, JCO oncology practice.

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies

L. Bernal-Mizrachi, H. Khoury, J. Galipeau, 2013, Cancer.